Skip to main
University-wide Navigation

College Creates Nuclear Magnetic Resonance Center; Names Subramanian Director

The University of Kentucky College of Pharmacy has created a new Nuclear Magnetic Resonance (NMR) Center, recruiting Vivekanandan Subramanian, PhD to serve as the Center’s inaugural director. NMR instruments are large magnets, similar to clinical MRI scanners, that allow researchers to measure the structure of small molecules and peptides.

Kentucky Pharmacists’ Collaboration Helps Secure $87 Million HEAL Grant

The opioid epidemic has taken hundreds of thousands of lives and devastated millions more. This problem has engaged the passion, knowledge, and persistence of researchers and health care providers who work on a daily basis to help people with opioid use disorder.

Kentucky Team Dedicated to Substance Use Disorder Research to Speak at Rx Summit

A group of individuals from the University of Kentucky (UK) is part of a new team dedicated to substance use disorder research at the university. These researchers combined their years of expertise to ensure UK takes a holistic approach when addressing substance use disorder in the Commonwealth. Recently, select members of this team have been invited to present at the National Rx Drug Abuse and Heroin Summit in Atlanta, GA and will be presenting their findings later this month.

A Closer Look at Blood-Brain Barrier Dysfunction in Epilepsy

New findings from the University of Kentucky published in the Journal of Neuroscience demonstrate that there may be ways to address blood-brain barrier dysfunction in epilepsy.

New Study Looks at Effects of Binge Drinking

The UK College of Pharmacy Research Publication Highlight for November of 2017 was published in Alcohol and is titled “Increased expression of M1 and M2 phenotypic markers in isolated microglia after four-day binge alcohol exposure in male rats” The project was led by Dr. Hui Peng, an Assistant Professor of Pharmaceutical Sciences in the laboratory of Dr. Kimberly Nixon, Associate Professor of Pharmaceutical Sciences. Graduate students Chelsea Geil and Kevin Chen as well as postdoctoral fellow, Justin McClain, each in the Nixon laboratory contributed to the project.

Getting in the Way of Cancer—Cell Signaling Interaction May Prevent Key Step November 06, 2017

New findings from University of Kentucky faculty published in Scientific Reportsreveals a novel cell signaling interaction that may prevent a key step in cancer progression. Kentucky continues to lead the nation in incidence and death rates from lung cancer, and the University of Kentucky College of Pharmacy is committed to reducing these numbers.

Detection Systems for Metastatic Colorectal Cancer

The UK College of Pharmacy Research Publication Highlight for October of 2017 was published in Pharmaceutical Research and is titled “Development of Halofluorochromic Polymer Nanoassemblies for the Potential Detection of Liver Metastatic Colorectal Cancer Tumors Using Experimental and Computational Approaches.”

University of Kentucky Takes Team Approach to Research

This summer, University of Kentucky’s Igniting Research Collaborations (IRC) awarded almost $300,000 in pilot grants to support cross-college interdisciplinary research and scholarship. This collaborative approach to science further enables research focused on health conditions prominent in the Commonwealth and beyond.

UK College of Pharmacy Receives $5 Million to Further Malaria Research

Approximately $5 million in additional funding from the Global Health Innovative Technology Fund (GHIT) has been awarded to the lab of Dean Kip Guy at the University of Kentucky College of Pharmacy, in partnership with Eisai Pharmaceuticals and Medicines for Malaria Venture (MMV), for ongoing malaria research. This award from GHIT funds research over two years with Dean Guy as the project's principal investigator.

College of Pharmacy to Host Symposium on Drug Discovery & Development

The UK College of Pharmacy will host its eighth annual Symposium on Drug Discovery and Development on Thursday, August 10, 2017. This year’s Symposium is in partnership with the College’s Natural Products Consortium. The Symposium will feature recent advances in the design of antibody-drug conjugates for treating cancer and other diseases, as well as advances in our understanding how Nature generates compounds that have been exploited in medicine, agriculture, and biotechnology.

Filter News

We wish to remember and honor those who inhabited this Commonwealth before the arrival of the Europeans. Briefly occupying these lands were the Osage, Wyndott tribe, and Miami peoples. The Adena and Hopewell peoples, who are recognized by the naming of the time period in which they resided here, were here more permanently. Some of their mounds remain in the Lexington area, including at UK’s Adena Park.

In more recent years, the Cherokee occupied southeast Kentucky, the Yuchi southwest Kentucky, the Chickasaw extreme western Kentucky and the Shawnee central Kentucky including what is now the city of Lexington. The Shawnee left when colonization pushed through the Appalachian Mountains. Lower Shawnee Town ceremonial grounds are still visible in Greenup County.

We honor the first inhabitants who were here, respect their culture, and acknowledge the presence of their descendants who are here today in all walks of life including fellow pharmacists and healthcare professionals.